TECX

Tectonic Therapeutic, Inc. TECX

NasdaqSmall CapHealthcare

13F Pro Quality Score

Not in ranked universe

Pending next ranking run

This company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. Rankings refresh on Jan 1, Apr 1, Jul 1, Oct 1.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Net income

$-22.29M

Quarter to Jun 30

Free cash flow

$-21.53M

Quarter to Jun 30

Top Institutional Holders

as of Q2 2026
$479.94M total
Reading the latest SEC filing…

Key Metrics

Net Income

Q2 2026
EDGAR

EPS (Diluted)

Q2 2026
EDGAR

ROIC

Q2 2026
EDGAR

Free Cash Flow

Q2 2026
EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/TECX

Earnings Per Share

13fpro.ai/company/TECX

Loading ratio trend…

TECX insiders

Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.

About Tectonic Therapeutic, Inc. (TECX): stock profile, AI score and financials

Tectonic Therapeutic, Inc. (TECX) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. TECX is not currently included in 13F Pro's AI-ranked quality universe — this company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. rankings refresh on jan 1, apr 1, jul 1, oct 1. Based on the latest XBRL financial filings (Q2 2026), Tectonic Therapeutic, Inc. reports net income of $-22.3M, free cash flow of $-21.5M. Top institutional holders of TECX by reported 13-F value include FMR, TCG Crossover Management, abrdn plc, based on the most recent SEC filings. TECX trades on the Nasdaq exchange and files with the SEC under CIK 1681087. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate TECX daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Tectonic Therapeutic, Inc. directly from SEC EDGAR.

Financials through the period ended SEC EDGAR: CIK 1681087 →